Literature DB >> 6488502

Anatomic correction of transposition of the great arteries associated with ventricular septal defect: midterm results in 50 patients.

O Bical, E Hazan, Y Lecompte, L Fermont, J Karam, M M Jarreau, T Tran Viet, D Sidi, F Leca, J Y Neveux.   

Abstract

From May 1977 to August 1982 50 patients who were 1.5 to 44 months old underwent anatomic correction of transposition of the great arteries (TGA) and closure of ventricular septal defect (VSD) at our institution. Thirty-nine patients underwent preliminary pulmonary arterial banding. Hospital mortality was 32%: four patients died as a result of technical problems, seven as a result of associated lesions, three of pulmonary hypertension, and two of left ventricular failure. Three other patients died after the first postoperative month (one of mediastinitis, one at reoperation for a residual VSD, and one of pulmonary hypertension). All 31 survivors are in excellent clinical condition and are in sinus rhythm after a mean follow-up period of 31 +/- 14 months. Twenty-five patients were reinvestigated by echocardiography (M mode and two-dimensional) and/or catheterization. Parameters of left ventricular contractility were within normal limits, but systolic aortic diameter was larger than normal (p less than .01). Seven patients had stenosis of the right ventricular outflow tract and five of these required reoperation. The two persistent problems with the anatomic correction of TGA associated with VSD are a relatively high operative mortality and secondary right outflow tract stenosis. However, use of this procedure results in better left ventricular function and fewer arrhythmias than does use of atrial repair techniques and also results in the use of the anatomically left ventricle as the systemic ventricle.

Entities:  

Mesh:

Year:  1984        PMID: 6488502     DOI: 10.1161/01.cir.70.5.891

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  The arterial switch operation for transposition and complex heart defects.

Authors:  D A Ott
Journal:  Tex Heart Inst J       Date:  1992

2.  Pulmonary hypertension in patients with complete transposition of the great arteries: midterm results after surgery.

Authors:  Y Nakajima; K Momma; M Seguchi; M Nakazawa; Y Imai
Journal:  Pediatr Cardiol       Date:  1996 Mar-Apr       Impact factor: 1.655

3.  Right ventricular function 10 years after the Mustard operation for transposition of the great arteries: analysis of size, shape, and wall motion.

Authors:  A N Redington; M L Rigby; P Oldershaw; D G Gibson; E A Shinebourne
Journal:  Br Heart J       Date:  1989-12

4.  Use of balloon dilatation to treat supravalvar pulmonary stenosis developing after anatomical correction for complete transposition.

Authors:  A Saxena; L V Fong; B C Ogilvie; B R Keeton
Journal:  Br Heart J       Date:  1990-08

5.  Long-term fate of the coronary arteries after the arterial switch operation in newborns with transposition of the great arteries.

Authors:  D Bonnet; P Bonhoeffer; J F Piéchaud; Y Aggoun; D Sidi; C Planché; J Kachaner
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

6.  Anatomic correction for transposition of the great arteries: first follow-up (38 patients).

Authors:  R J Klautz; J Ottenkamp; J M Quaegebeur; T N Buis-Liem; J Rohmer
Journal:  Pediatr Cardiol       Date:  1989       Impact factor: 1.655

7.  Anatomical correction for complete transposition and double outlet right ventricle: intermediate assessment of functional results.

Authors:  C Lincoln; A N Redington; K Li; S Mattos; E A Shinebourne; M L Rigby
Journal:  Br Heart J       Date:  1986-09

8.  The impact of a bicuspid pulmonary valve in the aortic position after arterial switch for transposition of the great arteries on neoaortic root dimension and function: a propensity score matched analysis.

Authors:  Bobae Jeon; Eun Seok Choi; Bo Sang Kwon; Tae-Jin Yun; Seul Gi Cha; Jae Suk Baek; Jeong Jin Yu; Chun Soo Park
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.